US Stock MarketDetailed Quotes

AMRX Amneal Pharmaceuticals

Watchlist
  • 7.440
  • +0.060+0.81%
Close Jul 26 16:00 ET
  • 7.440
  • 0.0000.00%
Post 20:01 ET
2.30BMarket Cap-10191P/E (TTM)

Amneal Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Amneal Pharmaceuticals Earnings Date

Currency: USD

Period

Q2 FY2024 Estimates

Aug 9, 2024

Revenue(YoY)

657.52M

+9.76%
EPS(YoY)

0.00

-100.00%
Analyst Rating

Strong Buy

Jun 30, 2024

Amneal Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 660.277M--
Aug 9, 20242024/Q2-- / 657.519M--
May 3, 20242024/Q1659.191M / 619.032M--
--2023/Q4616.981M / 634.858M--
Nov 7, 20232023/Q3620.040M / 604.527M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 660.277M--
Aug 9, 20242024/Q2-- / 657.519M--
May 3, 20242024/Q1659.191M / 619.032M--
--2023/Q4616.981M / 634.858M--
Nov 7, 20232023/Q3620.040M / 604.527M--

Unlock Free Earnings Estimates

Amneal Pharmaceuticals Earnings Reports

  • Amneal Pharmaceuticals | 10-Q: Quarterly report

    May 8 16:51 ET

  • Amneal Pharmaceuticals | 10-K: Annual report

    Mar 14 17:10 ET

  • Amneal Pharmaceuticals: Q3 2023 Earnings Report

    Nov 8, 2023 18:51 ET

  • Amneal Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 8, 2023 16:54 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 30, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg